Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic partnership agreem...
Target Health Inc. and dMed Biopharmaceuticals Company Limited have joined forces to help Western and Chinese biopharma ...
GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and ...
XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel s...
BeiGene, Ltd., a China headquartered commercial-stage biotechnology company focused on developing and commercializing in...
Henlius, a leading biotech company in China developing both biosimilar and innovative biologics, on 21 June 20...
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the t...
Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announc...
WuXi Biologics ("WuXi Bio"), a leading global open-access biologics technology platform company offering end-to-end solu...
CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for ca...
Holmusk has signed a Memorandum of Understanding (MoU) with Janssen (China) Research & Development Center (Janssen),...
Chengdu 23Mofang Biotech Company, a startup in Chengdu Tianfu Software Park, has recently published an academic pap...
Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"), a world leading internet medical and hea...
Varian has acquired Endocare® Systems, based in Austin, Texas; and Alicon, based in Hangzhou, China. Endo...
Varian has announced the Proton Clinical Research Center of the Shandong Cancer Hospital, is the first center in Asia Pa...
AXA Hong Kong, The Chinese University of Hong Kong (CUHK) and Oxford VR (OVR) have jointly launched a first-of...
Terns Pharmaceuticals has announced the initiation of Phase 1 clinical trial of TERN-101, a farnesoid X receptor (F...
Ms Kimberly Nearing, Head of Life Sciences at Cedrus Investments (Cedrus), was invited to moderate the fi...
